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Ischemia is a common and deleterious secondary injury following traumatic brain injury
(TBI). A great challenge for the treatment of TBI patients in the neurointensive care unit
(NICU) is to detect early signs of ischemia in order to prevent further advancement and
deterioration of the brain tissue.Today, several imaging techniques are available to monitor
cerebral blood flow (CBF) in the injured brain such as positron emission tomography (PET),
single-photon emission computed tomography, xenon computed tomography (Xenon-CT),
perfusion-weighted magnetic resonance imaging (MRI), and CT perfusion scan. An ideal
imaging technique would enable continuous non-invasive measurement of blood flow and
metabolism across the whole brain. Unfortunately, no current imaging method meets all
these criteria. These techniques offer snapshots of the CBF. MRI may also provide some
information about the metabolic state of the brain. PET provides images with high resolu-
tion and quantitative measurements of CBF and metabolism; however, it is a complex and
costly method limited to few TBI centers. All of these methods except mobile Xenon-CT
require transfer of TBI patients to the radiological department. Mobile Xenon-CT emerges
as a feasible technique to monitor CBF in the NICU, with lower risk of adverse effects.
Promising results have been demonstrated with Xenon-CT in predicting outcome in TBI
patients. This review covers available imaging methods used to monitor CBF in patients
with severe TBI.
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INTRODUCTION
Traumatic brain injury (TBI) is one of the leading causes of death
and disability in young adults. Acute TBI is characterized by a pri-
mary and a secondary injury. Primary brain injury is the direct
injury to the brain parenchyma at the time of the initial impact,
which can be both focal and diffuse depending on the biome-
chanics of the impact. The secondary brain injury is caused by a
combination of neuronal and vascular damage, proteolytic path-
ways, excitotoxicity, oxygen-free radicals, apoptosis, inflammatory
processes, and ischemia (1). Secondary brain injury may also be
caused by secondary clinical events, e.g., increased intracranial
pressure (ICP), hypotension, hypoxemia, seizures, and pyrexia (2).
Ischemia plays a major role in the pathology of TBI; signs
of ischemic brain damage are found on autopsy in more than
90% of TBI patients (3, 4). Astrup et al. demonstrated that the
critical ischemic cerebral blood flow (CBF) threshold for electri-
cal/functional disturbance was higher than the threshold for com-
plete electrical failure/infarction, which was the foundation for the
ischemic penumbra concept (5, 6). Jones et al. showed that the risk
of infarction was dependent both of the CBF level and duration of
time with decreased CBF (7). Furthermore, the degree and dura-
tion of decreased CBF was shown to be decisive of the outcome
(8) and correlated with injury severity following TBI (9, 10).
Another important observation was the “luxury perfusion syn-
drome” originally described by Lassen (11). This syndrome was
described as cerebral hyperemia or “over-abundant CBF relative
to the metabolic needs of the brain tissue.” Cerebral hyperemia
following brain injury has been demonstrated in several stud-
ies using intravenous Xenon-133 (12, 13). Normal and high CBF
with narrow arteriojugular venous difference of oxygen (AVDO2)
indicating “luxury perfusion” has been shown in comatose TBI
patients (14).
Areas surrounding the focal regions of reduced CBF display
milder reductions in flow following TBI (15, 16). It has been sug-
gested that this area is at risk for secondary insults but most
importantly, due to its viability, it is sensitive to therapeutic
interventions (17).
The brain has almost no capacity to survive without oxygen.
Its reserved oxygen capacity will only last for a few seconds. The
brain adenosine triphosphate (ATP), the fuel crucial for neuronal
functioning, will only last for 40 s during complete ischemia (18).
Furthermore, the level of ATP in brain tissue following TBI has
been shown to correlate to the severity of the brain injury (19).
Mean arterial pressure (MAP), ICP, PaCO2, and PaO2 are the
physiologic variables that would influence CBF. The most impor-
tant relationship, however, is the principle of flow-metabolism
coupling whereby cerebral metabolic rate of oxygen (CMRO2) is
directly related to CBF and AVDO2 (20).
Changes in CBF following TBI in patients have been described
as a triphasic pattern. During the first and acute phase, there is a
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50% decrease in CBF (21, 22). During the following initial 12 h
post-injury, the second phase begins, marked by a rise in CBF that
approaches or exceeds normal values in some patients and typi-
cally persists for the next 4–5 days (23). This phase is followed in
turn by a third period of low CBF that lasts for up to 2 weeks post-
injury. However, there is a strong heterogeneity of CBF among
TBI patients. In some patients, the CBF may persist low while
in others normal CBF values can be seen that remains for days
to weeks. The assessment of CBF following TBI is important to
detect episodes of ischemia. Ischemia in TBI patients regardless
of when detected has shown to be correlated with poor out-
come (21, 23, 24). It is important to relate CBF changes to the
metabolic demand where both metabolic depression and tran-
sient hyperglycolysis following TBI have been observed (25–27).
The episodes of high CBF paralleled the episodes of hypergly-
colysis and the question was raised whether low CBF in patients
following TBI always means an inadequate supply for metabolic
demand. Combining CBF imaging with microdialysis could show
that high lactate/pyruvate ratio, usually interpreted as ischemia,
occurred despite that the CBF was not low (28). This suggested that
the metabolic crises can be caused by mitochondrial dysfunction
rather than inadequate CBF.
A great challenge for the treatment of TBI patients in the neu-
rointensive care unit (NICU) is to detect early signs of secondary
brain injury in order to prevent further advancement and deteri-
oration of the brain tissue. Multimodality monitoring using focal
and global methods provides valuable information but has its limi-
tations. Imaging of the brain may add important information. An
ideal imaging technique would enable continuous non-invasive
measurement of regional blood flow and metabolism across the
whole brain. Currently, there are several methods that offer snap-
shots of the CBF, and some also provides information about the
metabolic state of the injured brain. The aim of this article is to give
a short review of currently available brain imaging methods used
in patients with severe TBI. Relevant references are summarized
in Table 1.
POSITRON EMISSION TOMOGRAPHY
Positron emission tomography (PET) is an imaging technique
that provides quantitative measurement of cerebral perfusion and
metabolism (78, 79). Positron emitting radionuclides are used
either after incorporation into chemical compounds (e.g., C15O,
C15O2, and H2150) or as molecular tracers (e.g., 15O2). After
intravenous administration or inhalation, the isotopic tracer is dis-
tributed in the tissues according to the physiological properties,
and the radioactive tracer concentration is measured regionally.
The radioisotopes, which are produced by a cyclotron, have short
half-life and must be used without delay. The detected regional
tracer concentrations allows for mathematical quantification of
CBF, cerebral blood volume (CBV), the oxygen extraction fraction
(OEF), and CMRO2 (80–82).
O15-radioisotope has been used to measure CBF and OEF, while
F19 deoxyglucose (FDG) assesses regional brain glucose metabo-
lism. FDG is analogous to glucose in the body. It rapidly crosses
the blood–brain barrier and is taken up into brain cells. Since FDG
is not further metabolized, it can be imaged to produce metabolic
maps for PET imaging. The images obtained are then generally
co-registered with CT or magnetic resonance imaging (MRI) to
obtain anatomic relationships (78, 79, 83).
Several studies have used PET in assessment of TBI (27, 28, 59,
60, 62–64, 84–86).
Regional brain ischemia was detected in TBI patients, who
underwent PET within 24 h following injury according to CBF,
OEF, and CMRO2 measurements, and an increase of the ischemic
volume was correlated with poor outcome (61).
By using PET, both hypo- and hyperglycolysis have been
demonstrated in TBI patients. In a study performed by Bergsneider
et al., it was shown that both global and regional hyperglycolysis
occur following severe TBI. Within 1 week following injury, 56%
of the patients showed evidence of hyperglycolysis using FDG-
PET (27). In a follow-up study, PET was performed within 4 days
following TBI, and a depressed cerebral metabolic rate of glucose
was observed (63).
Combining PET with microdialysis in TBI patients, Vespa et al.
demonstrated high lactate/pyruvate ratio that indicates metabolic
crises without presence of ischemia according to PET (28). It was
suggested that high lactate/pyruvate ratio under those circum-
stances indicated mitochondrial dysfunction rather than ischemia
(28, 87, 88).
One of the advantages of PET is that it can generate images
of greater resolution. The main advantage is that PET provides
the possibility to obtain quantitative regional measurements of
both CBF and metabolism. The drawbacks are that the genera-
tion of isotopes requires a costly cyclotron and is labor intensive.
In addition, the isotopes that are used have a shorter half-life
thereby requiring that the radiopharmaceuticals must be readily
available. Furthermore, PET provides a non-continuous measure-
ment and the need for transfer of the patient to a radiology unit
(61, 89).
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY
The principal of single-photon emission computed tomography
(SPECT) is similar to PET in using radioactive material to detect
gamma rays. The tracer usually used is the radioisotope 99mTc
that crosses the blood–brain barrier and localize in the brain tis-
sue in proportion to blood flow. SPECT is a semi-quantitative
CBF measurement technique that is based on the calculation of
tracer uptake ratios and an estimation of the relative regional CBF
(rCBF) distribution within the brain (90).
An initial study lesions detected by SPECT in TBI patients dur-
ing the first 72 h was compared to CT findings. It was shown
that SPECT detected 40% more lesions than shown by CT scans
(65). Similar results have been reported by Roper et al. (66). In
a study of eight patients with severe diffuse TBI, SPECT revealed
several lesions in all patients, even in non-depicted regions on
MRI (67). Abnormalities in cerebral perfusion were also observed
1–6 months following injury.
There are numerous publications proving SPECT functional
brain imaging as a powerful research tool, especially in the fields
of cerebrovascular disease and cognitive disorders, and there is
extensive development in receptor and molecular imaging (91).
In a recent systematic review, Raji et al. concluded that SPECT
imaging could be useful in evaluating patients with neurological
and psychiatrically sequela after TBI (92).
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Table 1 | Presents a summary of publications using Xenon-CT, PET, perfusion CT, perfusion-MRI, and comparative studies using different
imaging modalities.
Reference Subject Additional monitoring Time post-injury n GCS
XENON-CT
Yonas et al. (29, 30) CBF and TBI 1 GCS ≤ 8
Langfitt et al. (31) Imaging pathology and
neuropsychological tests (133Xe)
MRI, PET, CT,
Xenon-133
Acute and 6 months 3 GCS ≤ 13
Latchaw et al. (32) CBF in different types of TBI During NIC stay 35 GCS ≤ 8
Marion et al. (21) Xenon-CT and ICP Within 7 days 23 GCS ≤ 8
Schalen et al. (33) CBF and hyperventilation response
(133Xe)
Jugbulb During NIC stay 38 GCS ≤ 8
Marion et al. (21) CBF following TBI 1 h–7 days 32 GCS ≤ 7
Bouma et al. (23) Early measurement of CBF in TBI Jugbulb First 24 h 186 GCS ≤ 8
Bouma et al. (22) CBF in acute phase of severe TBI 3 h 35 GCS ≤ 8
Bouma et al. (22) Autoregulation test (133Xe) First days 47 GCS ≤ 8
Stringer et al. (34) CBF and hyperventilation During NIC stay 12
Bouma and Muizelaar (35) Xenon-CT evaluation in TBI
McLaughlin and Marion (36) CBF and vasoresponsivity in contusions 24–48 h 10 GCS ≤ 8
Kelly et al. (37) CBF and outcome (133Xe) 1–5 days 54 GCS ≤ 12
Schroder et al. (38) Relation of CBV and CBF to explain
cause of ischemia
Dynamic CT imaging
(CBV)
24 h 51 GCS ≤ 8
Bouma et al. (39) Underlying cause of cerebral swelling Dynamic CT imaging
(CBV)
Early posttrauma 37
Doppenberg et al. (40) Relation of potassium, glutamate,
lactate, and CBF
Microdialysis 70 GCS ≤ 8
Kushi et al. (41) CBF, C02, pH and CMR02 as prognostic
indicator
Jugbulb 22 GCS ≤ 8
Hoelper et al. (42) rCBF and contusions 29 and 94 h 44 GCS ≤ 8
von Oettingen et al. (43) TBI and pulmonary trauma, xenon
concentration and CBF
5
Schutt et al. (44) Thermo-dye-dilution and Xenon-CT Thermo-dye-dilution 1–5 days 16 GCS ≤ 8
Valadka et al. (45) CBF and pbr02 pbr02 18 GCS ≤ 6
Furuya et al. (46) CBF and hypodense area 50 GCS ≤ 8
Chieregato et al. (47) rCBF in traumatic hemorrhagic
contusions
14 GCS ≤ 9
Chieregato et al. (48) CBF and hypertension 7 GCS ≤ 8
Chieregato et al. (49) Recovery of CBF in tICH First 20 day 22 GCS ≤ 8
Inoue et al. (50) CBF and 6 months outcome 1,2, 3, 4, 6 weeks 20 GCS ≤ 8
Chieregato et al. (51) CBF in hematomas and traumatic
contusions
43 GCS ≤ 8
Poon et al. (52) C02 reactivity and cerebral
hemodynamics
TCD, ICP, Microdialysis 35 GCS ≤ 12
Marmarou et al. (53) Type of edema in diffuse and focal TBI DWI, MR 45 GCS ≤ 8
(Continued)
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Table 1 | Continued
Reference Subject Additional monitoring Time post-injury n GCS
Chieregato et al. (54) CBF and CPP levels Jugbulb During NIC stay 237 GCS ≤ 8
Masaoka (55) CBF during hypothermia Jugbulb 1–4 days 30 GCS ≤ 8
Robertson et al. (56) Genetic polymorphism of N03 and CBF 12 and 48 h 51 GCS ≤ 8
Kaloostian et al. (57) Outcome prediction within 12 h
following TBI
12 h 120 GCS ≤ 8
Shafer et al. (58) CBF and oxygen saturation INVOS During NIC stay 22 “Intubated”
PET
Bergsneider et al. (27) Cerebral hyperglycolysis in TBI patients 1–24 h 28 GCS ≤ 8
Hattori et al. (59) Metabolic rate of glucose and level of
consciousness
1–5 days 23 GCS ≤ 15
Coles et al. (60) Measurement of ischemic lesion 1–24 h 12 GCS ≤ 12
Coles et al. (61) Ischemic brain volume and outcome 1–72 h 15 GCS ≤ 12
Hattori et al. (62) characterize contusional,
pericontusional, and remote regions in
TBI
1–5 days 21 GCS 3-15
Wu et al. (63) Metabolic rate of glucose in gray matter 1–4 days 14 GCS ≤ 14
Cunningham et al. (64) Threshold for irreversible tissue damage 1–5 days 14 GCS ≤ 8
Vespa et al. (28) Microdialysis and PET Mean 36 h 19 GCS ≤ 14
SPECT
Abdel-Dayem et al. (65) SPECT correlated to CT 24 h 14 GCS ≤ 8
Roper et al. (66) SPECT correlated to CT 72 h 15 GCS ≤ 15
Ito et al. (67) Cerebral perfusion in diffuse brain injury
and relationship to atrophy
Within 1 week and
1–6 months
8 GCS ≤ 8
PERFUSION CT
Wintermark et al. (68) Correlation of CPP and CBF 61 GCS ≤ 8
Wintermark et al. (69) Prognostic value of admission CBF At admission 130 GCS ≤ 10
Soustiel et al. (70) Prognostic value of admission CBF At admission and l week 30 GCS ≤ 9
Huang et al. (71) Progression of cerebral contusions 1–6 h 22 GCS ≤ 8
Bendinelli et al. (72) CBF within the first 48 h following TBI 1–48 h 30 GCS ≤ 8
PERFUSION-MRI
Garnett et al. (73) rCVB in contusion 2–19 days 18 GCS ≤ 8 vs. ≥ 9
COMPARATIV STUDIES
Hagen et al. (74) Comparison PW-MRI and Xenon-CT 1–24 h 10 Stenosis, HCF, atrophy
Rempp et al. (75) PW-MRI and PET in healthy subjects 12 NC
Gillard et al. (76) Comparison CTP and PET in AVM and
gliomas
8 8 AVM, 2 glioma
Campbell et al. (77) Comparison PW-MRI and perfusion CT
in ischemic stroke
3–6 h 49 Acute stroke
CBF, cerebral blood flow; ICP, intracranial pressure; CPP, cerebral perfusion pressure; CT, computer tomography; rCBV, regional cerebral blood flow; tICH, traumatic
intracranial hematoma; pbrO2, partial brain oxygen tension; Jugbulb, jugular bulb; INVOS, brain tissue oxygen saturation.
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Although SPECT provide images with lower resolution than
PET, the radioisotope is significantly less expensive and longer
lasting with no need of cyclotrons. Implementation of SPECT
into clinical routine for estimation of rCBF in the acute phase of
TBI is however lacking.
STABLE XENON COMPUTED TOMOGRAPHY
Xenon computed tomography (Xenon-CT) utilizes inhalation of
a gas mixture containing 28% (30–35% in older studies) non-
radioactive xenon (131Xe) and oxygen. The Xenon gas is a radio
opaque, highly lipid soluble and capable of crossing the BBB. The
Kety–Schmidt equation is applied to measure regional and global
CBF. It provides primarily measurements of rCBF in the cortex
and has been used under a variety of clinical conditions to study
the pathophysiology and guide therapy regarding blood pressure
and ventilation management (29). The first report of Xenon-CT
in a TBI patient demonstrated that this technique could be used
to detect regions with loss of autoregulation and CO2 reactivity
(30). In a following Xenon-CT study including 35 TBI patients,
the feasibility of using Xenon-CT for detecting changes in CBF,
for guidance of the degree of hyperventilation, and for the iden-
tification of brain death was evaluated (32). Higher incidence of
ischemia (very low CBF) than previously assumed following TBI
could be demonstrated by Xenon-CT (35), which also was shown
to be associated to high early mortality (22). Studies on contu-
sions following TBI have shown that the CBF is concentrically
distributed, improving from the core to the periphery (47). In
traumatic hematomas, it was shown that low rCBF levels seen in
the perihematoma low-density area CBF recovered from day 2 and
forward and persistence ischemia was only seen in the core (49). It
appears that type of contusion is also determinant of rCBF, with
lower values in mixed contusions compared to hamorrhagic and
non-hamorrhagic contusions (42).
The Xenon-CT has also been used to evaluate the effect of dif-
ferent interventions performed in the NICU on CBF following
TBI. Chieregato et al. observed that rCBF in the intracontu-
sional low-density area having critically reduced initial values was
marginally affected by norepinephrine induced increase in cere-
bral perfusion pressure (CPP). However, in subjects starting from
non-critical baseline values, rCBF was significantly reduced (48).
Stringer et al. reported that hyperventilation in patients with acute
brain lesion reduced CBF substantially both within the lesion and
in apparently normal brain regions (34). Furthermore, the CBF
in contusions has been shown to be reduced but with preserved
CO2 reactivity. It was suggested that this area and the surrounding
parenchyma are hypersensitive to hyperventilation and hypoten-
sion and thus vulnerable to secondary injury (36). The CO2
reactivity has been suggested as a good early prognostic indica-
tor (41). In the study by Kushi et al., jugular bulb catheters were
used in combination with Xenon-CT. Xenon-CT with simultane-
ous multimodality monitoring have generated interesting results
regarding CBF and metabolism following TBI. Combining Xenon-
CT with cerebral microdialysis showed that loss of CO2 reactivity
was associated with increased ICP and increased lactate, glutamate
and glycerol dialyzate levels, and consistently a fatal outcome (52).
In another study, areas with low CBF showed increased levels of
glutamate (40).
Xenon computed tomography has also been combined with
tissue oxygen tension monitoring in TBI, and it showed a linear
relationship between pbrO2 and CBF (45).
Promising results have been demonstrated with Xenon-CT in
predicting outcome in TBI patients. Patients with low CBF that
returns to normal 2–3 weeks following severe TBI show better
neurological outcome that the group who had sustained low CBF
(50).
In a recent study, Xenon-CT was used to monitor CBF in the
first 12 h following injury in 120 TBI patients. It was shown that
measurement of CBF within the first 12 h predicts 6 months out-
come, and the best outcome prediction was obtained if Xenon-CT
was measured within 6 h following TBI (57). In TBI, patient with
pulmonary injury care should be taken in CBF analyses since end-
tidal and arterial xenon concentration curves can be a source of
error (43).
Previous studies indicate that endothelial nitric oxide synthase
(NO3) activity is important in maintaining CBF after TBI. Using
Xenon-CT, Robertson et al. studies the association of genetic poly-
morphism of NO3 and CBF following TBI. They showed that
patients with the C/C genotype had lowest CBF values and worse
outcome (56).
Xenon computed tomography is fast and provides quantitative
measurements of CBF. The big advantage is that by using a mobile
CT scanner there are no need to transport the patient to a differ-
ent setting, which is always associated with increase risk of adverse
events (93, 94). Other advantages are the short half-life and very
low risk of side effects of inhaled Xenon, which makes repeated
examinations more feasible. The very low risk of side effects was
demonstrated in a recent multicentre evaluation study concluding
that CBF measurements by Xenon-CT can be performed safely,
with a very low risk of adverse events, and no risk of permanent
morbidity or sequela could be detected (95). However, the brain
is exposed to a small dose of radiation.
Wintermark et al. reported a radiation dose of 3.5–10 mSv for
the whole xenon study (96). While Seifert et al. report that in the
case of brain partially located in the region of primary radiation,
a mean organ dose of 39 mSv was calculated, corresponding to an
effective does of 1.6 mSv (97).
In our hands, the effective dose for a complete Xenon-CT exam-
ination is 2.7 mSv (in-house investigation, data not published).
This dose can be compared to an annual mean background dose
in Sweden of 3 mSv.
BRAIN PERFUSION IMAGING
Cerebral perfusion is defined as the steady-state delivery of blood
to brain tissue per unit volume, measured in milliliters per 100 g
of tissue per minute. Perfusion imaging uses intravascular trac-
ers most commonly iodine or gadolinium contrasts depending on
imaging method. These methods take advantage of signal changes
that accompany the passage of tracer through the cerebrovascular
system. Contrasts used in MRI, such as gadolinium, are com-
pounds that work by altering the magnetic properties of nearby
hydrogen nuclei, while CT perfusion uses iodine contrast agents,
which are radiopaque (such as iohexol) (98, 99).
The data acquired can be used to generate color-coded maps
and quantification of various perfusion parameters, including
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CBF, CBV, mean transit time (MTT), and time to peak (TTP;
the time from the start of contrast agent injection to the time of
maximum enhancement). The two commonly used methods are
perfusion-MRI and CT perfusion and will be discussed below.
PERFUSION-WEIGHTED MRI
The most common technique for measuring perfusion parameters
with MRI is dynamic susceptibility contrast (DSC). DSC-MRI per-
fusion is also known as bolus-tracking MRI or perfusion-weighted
MRI (PW-MRI). We chose PW-MRI throughout this review. In
PW-MRI, a time series of fast T2-weighted images are acquired
when gadolinium contrast agent is injected. As gadolinium passes
through the tissues, it produces a reduction of T2 intensity depend-
ing on the local concentration. Curves showing intensity changes
based on the concentration of gadolinium over time can be gen-
erated. This time-to-signal intensity alteration can be processed
to extract parameters that reflect either CBF, CBV, or MTT. These
are linked by the equation CBF=CBV/MTT, also known as the
“central volume principle” (100, 101).
Studies on TBI using PW-MRI are limited. Garnett et al. used
PWI during the subacute phase of TBI in a small group of patients
and reported that regions of both normal-appearing and con-
tused brain may have an abnormal regional CBV and had worse
outcome (73). In a study including 10 patients with neurologi-
cal illness, PW-MRI was compared with Xenon-CT and showed a
good correlation of rCBF between these methods (74).
Perfusion-weighted MRI can be used together with diffusion-
weighted MRI (DWI), then the ischemic penumbra can be iden-
tified (102, 103). It can assess vascular patency if magnetic reso-
nance angiography (MRA) is added (104). PW-MRI was used in
healthy subjects to measure absolute values of rCBF and rCBV
and compares these to values obtained by PET. The values were
in agreement with previous findings using PET both in white and
gray matter (75). In a recent study, PW-MRI was compared with
CT perfusion, and it was found that PW-MRI is superior in pre-
cision and accuracy in identifying ischemic core and salvageable
tissue (77).
One of the advantages of PW-MRI is that the contrast agent
used is gadolinium that has fewer contraindications than iodinated
contrasts.
However, compared to CT scan the PW-MRI is relatively time-
consuming and more expensive. MRI scans are also less available
and more difficult to monitor patients in.
COMPUTED TOMOGRAPHY PERFUSION SCAN
In computed tomography perfusion (CTP), a native (unenhanced)
CT is obtained followed by infusion of iodinated contrast. The
concurrent acquisition of images after contrast injection allow
for the measurement of changes in tissue attenuation that occur
in the brain with time. Post processing of the data allows the
generation of color-coded maps and quantification of various
perfusion parameters, including CBF, CBV, MTT, and TTP. CTP
has been mainly used in the management of patients with acute
stroke and other cerebrovascular disorders since it provides an easy
and practical way of obtaining both structural and CBF pictures.
The first study performed with CTP in severe TBI included 130
patients and suggested that the number of arterial territories with
low rCBV values was an independent prognostic factor regarding
functional outcome (69). Same group examined the correlation
of CPP and CTP findings. They could discriminate between two
groups of patients; one without relationship between CBF and
corresponding CPP values, considered as preserved autoregula-
tion and the other group with strong correlation between CBF
and CPP, interpreted as impaired autoregulation. Interestingly,
the group with impaired autoregulation showed better clinical
outcome (68).
Two studies have examined cerebral contusions using CTP in
patients with TBI. In the first study, both contusional core and
the surrounding brain tissue were examined. It was shown that
early CBV and CBF maps corresponds better than an early native
CT scan with the findings of non-contrast CT scans after 1 week,
and therefore, CTP provides better early evaluation of tissue via-
bility (70). In the second study, CTP was performed within 6 h of
arrival, and contrast extravasation was predictive of hemorrhage
progression (71). A recent study performed CTP during the first
48 h following severe TBI and confirmed abnormal perfusion fol-
lowing TBI and detected areas of hypoperfusion in 60% of patients
that were not seen in conventional CT (72).
Measurement of CBF using CTP was compared with PET in
patients with arteriovenous malformations and gliomas. Good
correlation was found, although CTP had a tendency to overes-
timate CBF (76).
The advantages of CTP are that all units equipped with a CT
scanner can obtain perfusion images and it is fast. Disadvantages
include the exposure to radiation, potential for an allergic reac-
tion to the iodine contrast, contraindication to use iodine contrast
in case of renal insufficiency and the risk of inducing renal fail-
ure with repeated examinations, and the need to predetermine the
regions of interest before the scan. Furthermore, although quan-
titative values can be acquired with perfusion CT, the accuracy
of the flow values obtained has not been fully validated. It has
not been determined if the references for normal CBF and crit-
ical CBF thresholds as measured with PET or Xenon-CT can be
applied in perfusion CT. Perfusion CT uses an intravascular tracer
to measure intravascular CBF, which likely reflects a different phys-
iologic mechanism than that of PET and Xenon-CT, which employ
a diffusible trace.
CONCLUSION
Cerebral hypoperfusion and other CBF disturbances are com-
mon after TBI and play an important role in the development
of secondary brain injury. It has been difficult to integrate meth-
ods for quantitative rCBF measurements in neurointensive care,
which relies mainly on uni-focal or global monitoring methods
to detect cerebral ischemia or to evaluate different treatments
aimed at increasing CBF. There is a need of a rapid assess-
ment of CBF in the NIC unit without transportation of the
patient. Currently, bedside Xenon-CT is the only method ful-
filling these criteria. All other methods discussed above require
transfer of TBI patients to the radiological department. How-
ever, Xenon-CT can only provide quantitative measurements of
CBF. In order to assess parameters such as CBV, CMRglu, and
CMRO2, it is necessary to use perfusion imaging and PET. PET
is a complex and costly procedure with a need of cyclotron,
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which has limited its use to few TBI centers. None of the
current available methods provide continuous measurements
of CBF.
Bedside Xenon-CT emerges as an economical and more acces-
sible imaging technique with few adverse effects that can be used
in the routine NIC to measure CBF following TBI.
REFERENCES
1. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth
(2007) 99:4–9. doi:10.1093/bja/aem131
2. Rose J, Valtonen S, Jennett B. Avoidable factors contributing to death after head
injury. Br Med J (1977) 2:615–8. doi:10.1136/bmj.2.6087.615
3. Graham DI, Adams JH, Doyle D. Ischaemic brain damage in fatal non-missile
head injuries. J Neurol Sci (1978) 39:213–34. doi:10.1016/0022-510X(78)
90124-7
4. Graham DI, Ford I, Adams JH, Doyle D, Teasdale GM, Lawrence AE, et al.
Ischaemic brain damage is still common in fatal non-missile head injury. J
Neurol Neurosurg Psychiatry (1989) 52:346–50. doi:10.1136/jnnp.52.3.346
5. Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and
extracellular K+ and H+ at critical levels of brain ischemia. Stroke (1977)
8:51–7.
6. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia – the ischemic
penumbra. Stroke (1981) 12:723–5.
7. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, Fitzgibbon SJ, Degirolami
U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg
(1981) 54:773–82. doi:10.3171/jns.1981.54.6.0773
8. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to
degree and duration of ischemia. Ann Neurol (1983) 14:294–301. doi:10.1002/
ana.410140307
9. Graham DI, Adams JH. Ischaemic brain damage in fatal head injuries. Lancet
(1971) 1:265–6. doi:10.1016/S0140-6736(71)91003-8
10. Dietrich WD, Alonso O, Busto R, Prado R, Zhao W, Dewanjee MK, et al. Post-
traumatic cerebral ischemia after fluid percussion brain injury: an autoradi-
ographic and histopathological study in rats. Neurosurgery (1998) 43:585–93;
discussion 593–84. doi:10.1097/00006123-199809000-00105
11. Lassen NA. The luxury-perfusion syndrome and its possible relation to
acute metabolic acidosis localised within the brain. Lancet (1966) 2:1113–5.
doi:10.1016/S0140-6736(66)92199-4
12. Bruce DA, Langfitt TW, Miller JD, Schutz H, Vapalahti MP, Stanek A, et al.
Regional cerebral blood flow, intracranial pressure, and brain metabolism in
comatose patients. J Neurosurg (1973) 38:131–44. doi:10.3171/jns.1973.38.2.
0131
13. Enevoldsen EM, Cold G, Jensen FT, Malmros R. Dynamic changes in regional
CBF, intraventricular pressure, CSF pH and lactate levels during the acute phase
of head injury. J Neurosurg (1976) 44:191–214. doi:10.3171/jns.1976.44.2.0191
14. Obrist WD, Langfitt TW, Jaggi JL, Cruz J, Gennarelli TA. Cerebral blood flow
and metabolism in comatose patients with acute head injury. Relationship
to intracranial hypertension. J Neurosurg (1984) 61:241–53. doi:10.3171/jns.
1984.61.2.0241
15. DeWitt DS, Jenkins LW, Wei EP, Lutz H, Becker DP, Kontos HA. Effects of
fluid-percussion brain injury on regional cerebral blood flow and pial arterio-
lar diameter. J Neurosurg (1986) 64:787–94. doi:10.3171/jns.1986.64.5.0787
16. Dietrich WD, Alonso O, Busto R, Prado R, Dewanjee S, Dewanjee MK, et al.
Widespread hemodynamic depression and focal platelet accumulation after
fluid percussion brain injury: a double-label autoradiographic study in rats. J
Cereb Blood Flow Metab (1996) 16:481–9. doi:10.1097/00004647-199605000-
00015
17. Bramlett HM, Green EJ, Dietrich WD. Exacerbation of cortical and hippocam-
pal CA1 damage due to posttraumatic hypoxia following moderate fluid-
percussion brain injury in rats. J Neurosurg (1999) 91:653–9. doi:10.3171/jns.
1999.91.4.0653
18. Siesjo BK. Brain Energy Metabolism. New York, NY: John & Wiley (1978).
19. Marklund N, Salci K, Ronquist G, Hillered L. Energy metabolic changes in the
early post-injury period following traumatic brain injury in rats. Neurochem
Res (2006) 31:1085–93. doi:10.1007/s11064-006-9120-0
20. Reilly PL, Bullock R. Head Injury, Pathophysiology and Management. London:
Hodder Education (2005).
21. Marion DW, Darby J, Yonas H. Acute regional cerebral blood flow changes
caused by severe head injuries. J Neurosurg (1991) 74:407–14. doi:10.3171/jns.
1991.74.3.0407
22. Bouma GJ, Muizelaar JP, Stringer WA, Choi SC, Fatouros P, Young HF. Ultra-
early evaluation of regional cerebral blood flow in severely head-injured
patients using xenon-enhanced computerized tomography. J Neurosurg (1992)
77:360–8. doi:10.3171/jns.1992.77.3.0360
23. Bouma GJ, Muizelaar JP, Choi SC, Newlon PG, Young HF. Cerebral circula-
tion and metabolism after severe traumatic brain injury: the elusive role of
ischemia. J Neurosurg (1991) 75:685–93. doi:10.3171/jns.1991.75.5.0685
24. Overgaard J, Mosdal C, Tweed WA. Cerebral circulation after head injury. Part
3: does reduced regional cerebral blood flow determine recovery of brain func-
tion after blunt head injury? J Neurosurg (1981) 55:63–74. doi:10.3171/jns.
1981.55.1.0063
25. Jaggi JL, Obrist WD, Gennarelli TA, Langfitt TW. Relationship of early cere-
bral blood flow and metabolism to outcome in acute head injury. J Neurosurg
(1990) 72:176–82. doi:10.3171/jns.1990.72.2.0176
26. Hovda DA, Lee SM, Smith ML, Von Stuck S, Bergsneider M, Kelly D, et al. The
neurochemical and metabolic cascade following brain injury: moving from
animal models to man. J Neurotrauma (1995) 12:903–6. doi:10.1089/neu.1995.
12.903
27. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA,
et al. Cerebral hyperglycolysis following severe traumatic brain injury in
humans: a positron emission tomography study. J Neurosurg (1997) 86:241–51.
doi:10.3171/jns.1997.86.2.0241
28. Vespa P, Bergsneider M, Hattori N, Wu HM, Huang SC, Martin NA, et al. Meta-
bolic crisis without brain ischemia is common after traumatic brain injury:
a combined microdialysis and positron emission tomography study. J Cereb
Blood Flow Metab (2005) 25:763–74. doi:10.1038/sj.jcbfm.9600073
29. Yonas H, Gur D, Wolfson SK Jr, Good WF, Good BC, Latchaw RE. Xenon-
enhanced computerised tomographic cerebral blood flow mapping. Lancet
(1984) 1:1357. doi:10.1016/S0140-6736(84)91856-7
30. Yonas H, Snyder JV, Gur D, Good WF, Latchaw RE, Wolfson SK Jr, et al. Local
cerebral blood flow alterations (Xe-CT method) in an accident victim. J Com-
put Assist Tomogr (1984) 8:990–1. doi:10.1097/00004728-198410000-00038
31. Langfitt TW, Obrist WD, Alavi A, Grossman RI, Zimmerman R, Jaggi J, et al.
Computerized tomography, magnetic resonance imaging, and positron emis-
sion tomography in the study of brain trauma. Preliminary observations. J
Neurosurg (1986) 64:760–7. doi:10.3171/jns.1986.64.5.0760
32. Latchaw RE, Yonas H, Darby JM, Gur D, Pentheny SL. Xenon/CT cerebral
blood flow determination following cranial trauma. Acta Radiol Suppl (1986)
369:370–3.
33. Schalen W, Messeter K, Nordstrom CH. Cerebral vasoreactivity and the pre-
diction of outcome in severe traumatic brain lesions. Acta Anaesthesiol Scand
(1991) 35:113–22. doi:10.1111/j.1399-6576.1991.tb03258.x
34. Stringer WA, Hasso AN, Thompson JR, Hinshaw DB, Jordan KG.
Hyperventilation-induced cerebral ischemia in patients with acute brain
lesions: demonstration by xenon-enhanced CT. AJNR Am J Neuroradiol (1993)
14:475–84.
35. Bouma GJ, Muizelaar JP. Evaluation of regional cerebral blood flow in acute
head injury by stable xenon-enhanced computerized tomography. Acta Neu-
rochir Suppl (Wien) (1993) 59:34–40.
36. McLaughlin MR, Marion DW. Cerebral blood flow and vasoresponsivity within
and around cerebral contusions. J Neurosurg (1996) 85:871–6. doi:10.3171/jns.
1996.85.5.0871
37. Kelly DF, Martin NA, Kordestani R, Counelis G, Hovda DA, Bergsneider M,
et al. Cerebral blood flow as a predictor of outcome following traumatic brain
injury. J Neurosurg (1997) 86:633–41. doi:10.3171/jns.1997.86.4.0633
38. Schroder ML, Muizelaar JP, Fatouros P, Kuta AJ, Choi SC. Early cerebral blood
volume after severe traumatic brain injury in patients with early cerebral
ischemia. Acta Neurochir Suppl (1998) 71:127–30.
39. Bouma GJ, Muizelaar JP, Fatouros P. Pathogenesis of traumatic brain swelling:
role of cerebral blood volume. Acta Neurochir Suppl (1998) 71:272–5.
40. Doppenberg EM, Reinert M, Zauner A, Massie TS, Bullock R. Determinants of
cerebral extracellular potassium after severe human head injury. Acta Neurochir
Suppl (1999) 75:31–4.
41. Kushi H, Moriya T, Saito T, Kinoshita K, Shibuya T, Hayashi N. Importance of
metabolic monitoring systems as an early prognostic indicator in severe head
injured patients. Acta Neurochir Suppl (1999) 75:67–8.
www.frontiersin.org July 2014 | Volume 5 | Article 114 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rostami et al. Imaging of CBF in TBI
42. Hoelper BM, Reinert MM, Zauner A, Doppenberg E, Bullock R. rCBF in hem-
orrhagic, non-hemorrhagic and mixed contusions after severe head injury and
its effect on perilesional cerebral blood flow. Acta Neurochir Suppl (2000) 76:
21–5.
43. von Oettingen G, Bergholt B, Ostergaard L, Jensen LC, Gyldensted C, Astrup
J. Xenon CT cerebral blood flow in patients with head injury: influence of
pulmonary trauma on the input function. Neuroradiology (2000) 42:168–73.
doi:10.1007/s002340050039
44. Schutt S, Horn P, Roth H, Quintel M, Schilling L, Schmiedek P, et al.
Bedside monitoring of cerebral blood flow by transcranial thermo-dye-
dilution technique in patients suffering from severe traumatic brain injury
or subarachnoid hemorrhage. J Neurotrauma (2001) 18:595–605. doi:10.1089/
089771501750291837
45. Valadka AB, Hlatky R, Furuya Y, Robertson CS. Brain tissue PO2: correlation
with cerebral blood flow. Acta Neurochir Suppl (2002) 81:299–301.
46. Furuya Y, Hlatky R, Valadka AB, Diaz P, Robertson CS. Comparison of cere-
bral blood flow in computed tomographic hypodense areas of the brain
in head-injured patients. Neurosurgery (2003) 52:340–5; discussion 345–6.
doi:10.1227/01.NEU.0000043931.83041.AA
47. Chieregato A, Fainardi E, Tanfani A, Martino C, Pransani V, Cocciolo F, et al.
Mixed dishomogeneous hemorrhagic brain contusions. Mapping of cerebral
blood flow. Acta Neurochir Suppl (2003) 86:333–7.
48. Chieregato A, Fainardi E, Tanfani A, Sabia G, Martino C, Pascarella R, et al.
Induced acute arterial hypertension and regional cerebral flow in intracontu-
sional low density area. Acta Neurochir Suppl (2003) 86:361–5.
49. Chieregato A, Fainardi E, Servadei F, Tanfani A, Pugliese G, Pascarella R, et al.
Centrifugal distribution of regional cerebral blood flow and its time course
in traumatic intracerebral hematomas. J Neurotrauma (2004) 21:655–66.
doi:10.1089/0897715041269669
50. Inoue Y, Shiozaki T, Tasaki O, Hayakata T, Ikegawa H, Yoshiya K, et al. Changes
in cerebral blood flow from the acute to the chronic phase of severe head injury.
J Neurotrauma (2005) 22:1411–8. doi:10.1089/neu.2005.22.1411
51. Chieregato A, Compagnone C, Tanfani A, Ravaldini M, Tagliaferri F, Pas-
carella R, et al. Cerebral blood flow mapping in two different subtypes of
intraparenchymal hemorrhagic traumatic lesions. Acta Neurochir Suppl (2005)
95:159–64.
52. Poon WS, Ng SC, Chan MT, Lam JM, Lam WW. Cerebral blood flow (CBF)-
directed management of ventilated head-injured patients. Acta Neurochir Suppl
(2005) 95:9–11. doi:10.1007/3-211-32318-X_2
53. Marmarou A, Signoretti S, Aygok G, Fatouros P, Portella G. Traumatic brain
edema in diffuse and focal injury: cellular or vasogenic? Acta Neurochir Suppl
(2006) 96:24–9. doi:10.1007/3-211-30714-1_6
54. Chieregato A, Tanfani A, Compagnone C, Turrini C, Sarpieri F, Ravaldini M,
et al. Global cerebral blood flow and CPP after severe head injury: a xenon-CT
study. Intensive Care Med (2007) 33:856–62. doi:10.1007/s00134-007-0604-4
55. Masaoka H. Cerebral blood flow and metabolism during mild hypothermia in
patients with severe traumatic brain injury. J Med Dent Sci (2010) 57:133–8.
56. Robertson CS, Gopinath SP, Valadka AB, Van M, Swank PR, Goodman JC.
Variants of the endothelial nitric oxide gene and cerebral blood flow after
severe traumatic brain injury. J Neurotrauma (2011) 28:727–37. doi:10.1089/
neu.2010.1476
57. Kaloostian P, Robertson C, Gopinath SP, Stippler M, King CC, Qualls C,
et al. Outcome prediction within twelve hours after severe traumatic brain
injury by quantitative cerebral blood flow. J Neurotrauma (2012) 29:727–34.
doi:10.1089/neu.2011.2147
58. Shafer R, Brown A, Taylor C. Correlation between cerebral blood flow and
oxygen saturation in patients with subarachnoid hemorrhage and traumatic
brain injury. J Neurointerv Surg (2011) 3:395–8. doi:10.1136/jnis.2010.004184
59. Hattori N, Huang SC, Wu HM, Yeh E, Glenn TC, Vespa PM, et al. Correlation
of regional metabolic rates of glucose with glasgow coma scale after traumatic
brain injury. J Nucl Med (2003) 44:1709–16.
60. Coles JP, Fryer TD, Smielewski P, Rice K, Clark JC, Pickard JD, et al. Defin-
ing ischemic burden after traumatic brain injury using 15O PET imag-
ing of cerebral physiology. J Cereb Blood Flow Metab (2004) 24:191–201.
doi:10.1097/01.WCB.0000100045.07481.DE
61. Coles JP, Fryer TD, Smielewski P, Chatfield DA, Steiner LA, Johnston AJ, et al.
Incidence and mechanisms of cerebral ischemia in early clinical head injury. J
Cereb Blood Flow Metab (2004) 24:202–11. doi:10.1097/01.WCB.0000103022.
98348.24
62. Hattori N, Huang SC, Wu HM, Liao W, Glenn TC, Vespa PM, et al. Acute
changes in regional cerebral (18)F-FDG kinetics in patients with traumatic
brain injury. J Nucl Med (2004) 45:775–83.
63. Wu HM, Huang SC, Hattori N, Glenn TC, Vespa PM, Yu CL, et al. Selective
metabolic reduction in gray matter acutely following human traumatic brain
injury. J Neurotrauma (2004) 21:149–61. doi:10.1089/089771504322778613
64. Cunningham AS, Salvador R, Coles JP, Chatfield DA, Bradley PG, Johnston
AJ, et al. Physiological thresholds for irreversible tissue damage in contu-
sional regions following traumatic brain injury. Brain (2005) 128:1931–42.
doi:10.1093/brain/awh536
65. Abdel-Dayem HM, Sadek SA, Kouris K, Bahar RH, Higazi I, Eriksson S, et al.
Changes in cerebral perfusion after acute head injury: comparison of CT with
Tc-99m HM-PAO SPECT. Radiology (1987) 165:221–6.
66. Roper SN, Mena I, King WA, Schweitzer J, Garrett K, Mehringer CM,
et al. An analysis of cerebral blood flow in acute closed-head injury using
technetium-99m-HMPAO SPECT and computed tomography. J Nucl Med
(1991) 32:1684–7.
67. Ito H, Ishii K, Onuma T, Kawashima R, Fukuda H. Cerebral perfusion changes
in traumatic diffuse brain injury; IMP SPECT studies. Ann Nucl Med (1997)
11:167–72. doi:10.1007/BF03164829
68. Wintermark M, Chiolero R, Van Melle G, Revelly JP, Porchet F, Regli L, et al.
Relationship between brain perfusion computed tomography variables and
cerebral perfusion pressure in severe head trauma patients. Crit Care Med
(2004) 32:1579–87. doi:10.1097/01.CCM.0000130171.08842.72
69. Wintermark M, Van Melle G, Schnyder P, Revelly JP, Porchet F, Regli L, et al.
Admission perfusion CT: prognostic value in patients with severe head trauma.
Radiology (2004) 232:211–20. doi:10.1148/radiol.2321030824
70. Soustiel JF, Mahamid E, Goldsher D, Zaaroor M. Perfusion-CT for early assess-
ment of traumatic cerebral contusions. Neuroradiology (2008) 50:189–96.
doi:10.1007/s00234-007-0337-7
71. Huang AP, Lee CW, Hsieh HJ, Yang CC, Tsai YH, Tsuang FY, et al. Early
parenchymal contrast extravasation predicts subsequent hemorrhage pro-
gression, clinical deterioration, and need for surgery in patients with trau-
matic cerebral contusion. J Trauma (2011) 71:1593–9. doi:10.1097/TA.
0b013e31822c8865
72. Bendinelli C, Bivard A, Nebauer S, Parsons MW, Balogh ZJ. Brain CT perfusion
provides additional useful information in severe traumatic brain injury. Injury
(2013) 44:1208–12. doi:10.1016/j.injury.2013.03.039
73. Garnett MR, Blamire AM, Corkill RG, Rajagopalan B, Young JD, Cadoux-
Hudson TA, et al. Abnormal cerebral blood volume in regions of con-
tused and normal appearing brain following traumatic brain injury using
perfusion magnetic resonance imaging. J Neurotrauma (2001) 18:585–93.
doi:10.1089/089771501750291828
74. Hagen T, Bartylla K, Piepgras U. Correlation of regional cerebral blood flow
measured by stable xenon CT and perfusion MRI. J Comput Assist Tomogr
(1999) 23:257–64. doi:10.1097/00004728-199903000-00015
75. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of
regional cerebral blood flow and volume with dynamic susceptibility contrast-
enhanced MR imaging. Radiology (1994) 193:637–41.
76. Gillard JH, Minhas PS, Hayball MP, Bearcroft PW, Antoun NM, Freer CE, et al.
Assessment of quantitative computed tomographic cerebral perfusion imaging
with H2(15)O positron emission tomography. Neurol Res (2000) 22:457–64.
77. Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM,
et al. Comparison of computed tomography perfusion and magnetic reso-
nance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke (2012)
43:2648–53. doi:10.1161/STROKEAHA.112.660548
78. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD,
et al. The [14C]deoxyglucose method for the measurement of local cerebral
glucose utilization: theory, procedure, and normal values in the conscious and
anesthetized albino rat. J Neurochem (1977) 28:897–916. doi:10.1111/j.1471-
4159.1977.tb10649.x
79. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, et al. The
[18F]fluorodeoxyglucose method for the measurement of local cerebral glucose
utilization in man. Circ Res (1979) 44:127–37. doi:10.1161/01.RES.44.1.127
80. Ter-Pogossian MM, Eichling JO, Davis DO, Welch MJ. The measure in vivo of
regional cerebral oxygen utilization by means of oxyhemoglobin labeled with
radioactive oxygen-15. J Clin Invest (1970) 49:381–91. doi:10.1172/JCI106247
81. Frackowiak RS, Lenzi GL, Jones T, Heather JD. Quantitative measurement
of regional cerebral blood flow and oxygen metabolism in man using 15O
Frontiers in Neurology | Neurotrauma July 2014 | Volume 5 | Article 114 | 8
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rostami et al. Imaging of CBF in TBI
and positron emission tomography: theory, procedure, and normal values.
J Comput Assist Tomogr (1980) 4:727–36. doi:10.1097/00004728-198012000-
00001
82. Herscovitch P, Markham J, Raichle ME. Brain blood flow measured with
intravenous H2(15)O. I. Theory and error analysis. J Nucl Med (1983) 24:
782–9.
83. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, et al. Measurement
of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-
glucose. Acta Neurol Scand Suppl (1977) 64:190–1.
84. Pickard JD, Hutchinson PJ, Coles JP, Steiner LA, Johnston AJ, Fryer TD, et al.
Imaging of cerebral blood flow and metabolism in brain injury in the ICU.
Acta Neurochir Suppl (2005) 95:459–64. doi:10.1007/3-211-32318-X_94
85. Menon DK. Brain ischaemia after traumatic brain injury: lessons from
15O2 positron emission tomography. Curr Opin Crit Care (2006) 12:85–9.
doi:10.1097/01.ccx.0000216572.19062.8f
86. Kato T, Nakayama N, Yasokawa Y, Okumura A, Shinoda J, Iwama T. Statisti-
cal image analysis of cerebral glucose metabolism in patients with cognitive
impairment following diffuse traumatic brain injury. J Neurotrauma (2007)
24:919–26. doi:10.1089/neu.2006.0203
87. Clausen T, Zauner A, Levasseur JE, Rice AC, Bullock R. Induced mitochondrial
failure in the feline brain: implications for understanding acute post-traumatic
metabolic events. Brain Res (2001) 908:35–48. doi:10.1016/S0006-8993(01)
02566-5
88. Nielsen TH, Bindslev TT, Pedersen SM, Toft P, Olsen NV, Nordstrom CH.
Cerebral energy metabolism during induced mitochondrial dysfunction. Acta
Anaesthesiol Scand (2013) 57:229–35. doi:10.1111/j.1399-6576.2012.02783.x
89. Nortje J, Gupta AK. The role of tissue oxygen monitoring in patients with acute
brain injury. Br J Anaesth (2006) 97:95–106. doi:10.1093/bja/ael137
90. Levin CS. Primer on molecular imaging technology. Eur J Nucl Med Mol Imag-
ing (2005) 32:S325–45. doi:10.1007/s00259-005-1973-y
91. Devous MD Sr. Single-photon emission computed tomography in neurother-
apeutics. NeuroRx (2005) 2:237–49. doi:10.1602/neurorx.2.2.237
92. Raji CA, Tarzwell R, Pavel D, Schneider H, Uszler M, Thornton J, et al.
Clinical utility of SPECT neuroimaging in the diagnosis and treatment of
traumatic brain injury: a systematic review. PLoS One (2014) 9:e91088.
doi:10.1371/journal.pone.0091088
93. Hillman J, Sturnegk P, Yonas H, Heron J, Sandborg M, Gunnarsson T,
et al. Bedside monitoring of CBF with xenon-CT and a mobile scanner: a
novel method in neurointensive care. Br J Neurosurg (2005) 19:395–401.
doi:10.1080/02688690500389898
94. Sturnegk P, Mellergard P, Yonas H, Theodorsson A, Hillman J. Potential use
of quantitative bedside CBF monitoring (Xe-CT) for decision making in
neurosurgical intensive care. Br J Neurosurg (2007) 21:332–9. doi:10.1080/
02688690701411574
95. Carlson AP, Brown AM, Zager E, Uchino K, Marks MP, Robertson C, et al.
Xenon-enhanced cerebral blood flow at 28% xenon provides uniquely safe
access to quantitative, clinically useful cerebral blood flow information: a
multicenter study. AJNR Am J Neuroradiol (2011) 32:1315–20. doi:10.3174/
ajnr.A2522
96. Wintermark M, Sesay M, Barbier E, Borbely K, Dillon WP, Eastwood JD, et al.
Comparative overview of brain perfusion imaging techniques. Stroke (2005)
36:e83–99. doi:10.1161/01.STR.0000177884.72657.8b
97. Seifert H, Blass G, Leetz HK, Voges M. The radiation exposure of the
patient from stable-xenon computed tomography. Br J Radiol (1995) 68:301–5.
doi:10.1259/0007-1285-68-807-301
98. Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J
Magn Reson Imaging (2001) 13:496–520. doi:10.1002/jmri.1073
99. Grandin CB. Assessment of brain perfusion with MRI: methodology and appli-
cation to acute stroke. Neuroradiology (2003) 45:755–66. doi:10.1007/s00234-
003-1024-y
100. Rosen BR, Belliveau JW,Vevea JM, Brady TJ. Perfusion imaging with NMR con-
trast agents. Magn Reson Med (1990) 14:249–65. doi:10.1002/mrm.1910140211
101. Lia TQ, Guang Chen Z, Ostergaard L, Hindmarsh T, Moseley ME. Quantifica-
tion of cerebral blood flow by bolus tracking and artery spin tagging methods.
Magn Reson Imaging (2000) 18:503–12. doi:10.1016/S0730-725X(00)00137-5
102. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-
Hellinger FR, et al. Hyperacute stroke: evaluation with combined multisection
diffusion-weighted and hemodynamically weighted echo-planar MR imaging.
Radiology (1996) 199:391–401.
103. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR,
et al. Enlargement of human cerebral ischemic lesion volumes measured by
diffusion-weighted magnetic resonance imaging. Ann Neurol (1997) 41:581–9.
doi:10.1002/ana.410410506
104. Staroselskaya IA, Chaves C, Silver B, Linfante I, Edelman RR, Caplan L, et al.
Relationship between magnetic resonance arterial patency and perfusion-
diffusion mismatch in acute ischemic stroke and its potential clinical use. Arch
Neurol (2001) 58:1069–74. doi:10.1001/archneur.58.7.1069
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 07 April 2014; accepted: 16 June 2014; published online: 07 July 2014.
Citation: Rostami E, Engquist H and Enblad P (2014) Imaging of cerebral blood flow
in patients with severe traumatic brain injury in the neurointensive care. Front. Neurol.
5:114. doi: 10.3389/fneur.2014.00114
This article was submitted to Neurotrauma, a section of the journal Frontiers in
Neurology.
Copyright © 2014 Rostami, Engquist and Enblad. This is an open-access article dis-
tributed under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
www.frontiersin.org July 2014 | Volume 5 | Article 114 | 9
